Bioxytran, Inc. (BIXT)
OTCMKTS · Delayed Price · Currency is USD
0.0211
-0.0021 (-8.86%)
Sep 25, 2026, 3:59 PM EST
Bioxytran Employees
Bioxytran had 2 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
2
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
n/a
Market Cap
2.31M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 2 | 0 | - |
| Dec 31, 2024 | 2 | -1 | -33.33% |
| Dec 31, 2023 | 3 | 1 | 50.00% |
| Dec 31, 2022 | 2 | 0 | - |
| Dec 31, 2021 | 2 | 0 | - |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| CASI Pharmaceuticals | 214 |
| BioAtla | 41 |
| International Stem Cell | 33 |
| Vaccinex | 27 |
| AccuStem Sciences | 4 |
| Abpro Holdings | 3 |
Bioxytran News
- 6 weeks ago - Bioxytran Quarterly report: Q2 2026 - Filings
- 7 weeks ago - Bioxytran Leverages Artificial Super Intelligence (ASI) to Design Broad-Spectrum Antiviral and Anti-Cancer Metastasis Drugs - GlobeNewsWire
- 1 month ago - Bioxytran Announces Publication of Corporate Research Report by Globe Small Cap Research - GlobeNewsWire
- 3 months ago - Bioxytran Highlights New Book on Real-Time Monitoring Tissue Oxygenation Relevant to Oxygen Carrier BXT-25 - GlobeNewsWire
- 4 months ago - Bioxytran Quarterly report: Q1 2026 - Filings
- 5 months ago - Bioxytran Annual report: Q4 2025 - Filings
- 6 months ago - BIOXYTRAN, INC. COMPLETES $1.2 MILLION PRIVATE PLACEMENT - GlobeNewsWire
- 6 months ago - Bioxytran Announces Positive Dose Optimization Results and Advances Toward Phase 3 Registrational Trial for ProLectin-M - GlobeNewsWire